![Chung-Gil Kang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 4 M $ au 30/06/2026
Chung-Gil Kang currently works at OliX Pharmaceuticals, Inc., as Director, VP & Head-Management Planning.
Mr. Kang received his undergraduate degree and graduate degree from Korea Advanced Institute of Science & Technology.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/05/2026 | 42 500 ( 0,21 % ) | 4 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| OLIX PHARMACEUTICALS, INC | Directeur/Membre du Conseil | 19/03/2019 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Korea Advanced Institute of Science & Technology
 Korea Advanced Institute of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OliX Pharmaceuticals, Inc.
 OliX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs against locally treatable diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
